[PDF][PDF] 精神分裂症的药物联合治疗

管晓波, 陆峥 - 世界临床药物, 2015 - jwph.com.cn
… two antipsychotic agents in schizophreniais is widely used in clinical management. This
review describes the status of antipsychotic combination therapy for schizophrenia. Key words: …

探討雙極性情感疾患認知功能及其中維生素D 的角色

陳文瑩 - 2022 - tdr.lib.ntu.edu.tw
… Some evidence suggests that atypical antipsychotics and … Items for Systematic Reviews and
MetaAnalyses (PRISMA) … This systematic review and meta-analysis was prepared according …

乳酸: 一种精神疾病治疗的潜在靶点

Y Cai, H Guo, T Han, H Wang - 中国神经再生研究(英文版), 2024 - sjzsyj.com.cn
… In this review, we describe how antipsychotics targeting newer neurotransmitters offer a
promising … schizophrenia and bipolar disorder: a systematic review of findings from magnetic …

[PDF][PDF] 难治性精神分裂症药物治疗进展

陆铖, 马瑞, 高华, 贾乐川 - Clinical Medication Journal, 2023 - lcywzlzz.com
… with sertraline and ziprasidone monotherapy for treatment-… in treatment-resistant schizophrenia:
a systematic review[J]. Ther … augmentation of clozapine in schizophrenia:a sys⁃ tematic …

[引用][C] 中華民國92 年6 月第十五卷第三期June 2003 Volume 15 Number 3 精神分裂症: 注意力缺損與NMDA 假說藍先元呂宗達張文和中國醫藥學院附設醫院精神科神經科 …

HY Lane, TT Lu, WH Chang

[PDF][PDF] 以5-羟色胺2A受体为靶点的抗抑郁药研究进展*

徐祥清, 常山泉 - 医药导报, 2023 - yydbzz.com
monotherapy for treatment of patients with acute depression:a systematic review and
meta-analysis[J].… Cariprazine augmentation to antidepressant therapy in major depressive …

[HTML][HTML] HIV 暴露前预防药物的研究进展

刘杞梓, 杨雪, 徐鹏, 秦倩倩, 汤后林 - 中华流行病学杂志, 2022 - html.rhhz.net
: 2012 年WHO 发布了将替诺福韦/恩曲他滨(TDF/FTC) 作为HIV 暴露前预防(PrEP) 药物用于降低
特定人群中HIV 感染风险, 各类临床试验及真实世界的数据均证实了TDF/FTC 在预防HIV 感染…